Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.62
+0.39 (2.56%)
Sep 30, 2026, 12:08 PM EDT - Market open
Cullinan Therapeutics Employees
Cullinan Therapeutics had 109 employees as of December 31, 2025. The number of employees decreased by 2 or -1.80% compared to the previous year.
Employees
109
Change (1Y)
-2
Growth (1Y)
-1.80%
Revenue / Employee
n/a
Profits / Employee
-$1,911,404
Market Cap
1.01B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 109 | -2 | -1.80% | 109 | 0 |
| Dec 31, 2024 | 111 | 26 | 30.59% | 111 | 0 |
| Dec 31, 2023 | 85 | 23 | 37.10% | 85 | 0 |
| Dec 31, 2022 | 62 | 31 | 100.00% | 62 | 0 |
| Mar 31, 2022 | 37 | 13 | 54.17% | 37 | 0 |
| Dec 31, 2021 | 31 | 7 | 29.17% | 31 | 0 |
| Sep 30, 2021 | 33 | 15 | 83.33% | 33 | 0 |
| Jun 30, 2021 | 28 | 11 | 64.71% | 28 | 0 |
| Mar 31, 2021 | 24 | 7 | 41.18% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| Alumis | 239 |
| Monte Rosa Therapeutics | 173 |
| Janux Therapeutics | 113 |
| Adlai Nortye Group | 109 |
| Odyssey Therapeutics | 100 |
| Cybin | 100 |
| SpyGlass Pharma | 76 |
CGEM News
- 5 days ago - Cullinan Therapeutics price target raised to $35 from $30 at H.C. Wainwright - TheFly
- 5 days ago - Cullinan Therapeutics Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts
- 5 days ago - Cullinan Therapeutics share weakness provides buying opportunity, says TD Cowen - TheFly
- 6 days ago - Cullinan falls after pushing rheumatoid arthritis data to December - TheFly
- 6 days ago - Cullinan Therapeutics outlines Q4 2026 milestones across pipeline - TheFly
- 6 days ago - Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio - GlobeNewsWire
- 9 days ago - Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 15 days ago - Cullinan Therapeutics price target raised to $40 from $39 at BTIG - TheFly